Coronary blood flow responses to physiological stress in humans

Noninvasive transthoracic and transesophageal Doppler echocardiographic measurements of human coronary blood flow velocity: In vitro flow phantom validation

Coronary angiography is limited in assessing the hemodynamic significance of a coronary lesion or the state of the coronary microcirculation. Noninvasive transthoracic (TTE) and transesophageal (TEE) Doppler echocardiography have been used to measure coronary blood flow velocity and coronary flow reserve and thus the physiology of the coronary vasculature (normal, stable or unstable lesions). A fundamental, in vitro validation of these methods with a tissue and blood mimicking flow phantom has not been reported. Accordingly, Bland-Altman 95% confidence levels for precision (repeated measures) and accuracy (comparison with time collection) were determined for both TTE and TEE measurements of simulated coronary diastolic blood velocities in 2 mm and 4 mm vessels at the normal in vivo depths of 40 mm and 60 mm. The Doppler angle was set at 45 degrees and flow velocities were varied within a normal in vivo range of 0- 150 cm/s. Confidence levels for precisions and accuracies were similar between TTE and TEE and ranged from ± 6 cm/s to ± 13 cm/s or approximately 10-15% over the range of the measured velocities. These in vitro results in a controlled flow phantom suggest that technically adequate TTE and TEE can be used to reliably measure epicardial coronary conduit artery blood flow velocities.

Revisiting the role of oxygen therapy in cardiac patients

Over the past century, multiple studies lacking the precision of today's advanced technology provided conflicting data on the effects of oxygen therapy in normoxic cardiac patients. More importantly, no randomized, blinded, controlled studies have shown a benefit of such treatment. Yet the use of supplemental oxygen is widespread in cardiac patients. In these conditions, inadvertent hyperoxia commonly occurs because of concerns to ensure sufficient oxygenation and because hyperoxia is not perceived to be detrimental. In recent years, there has been mounting evidence demonstrating the potential adverse effects of hyperoxia on the cardiovascular system. In this report, we review data examining the effects of supplemental oxygen in normoxic patients with acute presentations of coronary artery disease. It is also the aim of this report to emphasize the point that oxygen therapy might have major adverse physiologic effects that must be considered when it is employed.

Muscle metaboreflex-induced coronary vasoconstriction functionally limits increases in ventricular contractility

Muscle metaboreflex activation during dynamic exercise induces a substantial increase in cardiac work and oxygen demand via a significant increase in heart rate, ventricular contractility, and afterload. This increase in cardiac work should cause coronary metabolic vasodilation. However, little if any coronary vasodilation is observed due to concomitant sympathetically induced coronary vasoconstriction. The purpose of the present study is to determine whether the restraint of coronary vasodilation functionally limits increases in left ventricular contractility. Using chronically instrumented, conscious dogs (n = 9), we measured mean arterial pressure, cardiac output, and circumflex blood flow and calculated coronary vascular conductance, maximal derivative of ventricular pressure (dp/dt(max)), and preload recruitable stroke work (PRSW) at rest and during mild exercise (2 mph) before and during activation of the muscle metaboreflex. Experiments were repeated after systemic alpha(1)-adrenergic blockade ( approximately 50 microg/kg prazosin). During prazosin administration, we observed significantly greater increases in coronary vascular conductance (0.64 + or - 0.06 vs. 0.46 + or - 0.03 ml x min(-1) x mmHg(-1); P < 0.05), circumflex blood flow (77.9 + or - 6.6 vs. 63.0 + or - 4.5 ml/min; P < 0.05), cardiac output (7.38 + or - 0.52 vs. 6.02 + or - 0.42 l/min; P < 0.05), dP/dt(max) (5,449 + or - 339 vs. 3,888 + or - 243 mmHg/s; P < 0.05), and PRSW (160.1 + or - 10.3 vs. 183.8 + or - 9.2 erg.10(3)/ml; P < 0.05) with metaboreflex activation vs. those seen in control experiments. We conclude that the sympathetic restraint of coronary vasodilation functionally limits further reflex increases in left ventricular contractility.